HOME >> BIOLOGY >> NEWS
AAAS releases video and first board consensus statement on climate change

18 FEBRUARY -- The American Association for the Advancement of Science (AAAS) today released a new video as well as the first consensus statement of its board of directors regarding global climate change during a free public town hall meeting in San Francisco, California.

The town hall meeting, part of the 2007 AAAS Annual Meeting, was organized by AAAS in collaboration with three leading U.S. education organizations -- the California Science Teachers Association, the National Science Teachers Association, and the United Educators of San Francisco (representing the National Education Association and the American Federation of Teachers).

Reflecting a growing torrent of evidence, the AAAS Board statement confirms that "global climate change caused by human activities is occurring now, and it is a growing threat to society." Fossil-fuel burning and deforestation have contributed to an atmospheric carbon-dioxide level that is higher than it has been for at least 650,000 years. As a result, "the average temperature of the Earth is heading for levels not experienced for millions of years," the AAAS board concluded.

Already, "Scientists are observing rapid melting of glaciers, destabilization of major ice sheets, rising sea levels, shifts in species ranges, and increased frequency of weather extremes," AAAS President John P. Holdren wrote in a cover letter to town hall attendees. "As droughts, heat waves, floods, wildfires, and severe storms intensify, damages to ecosystems and human society are growing apace."

Some of the most dramatic changes are being experienced in the far North, where temperatures have risen much more rapidly than the global average, according to Holdren, who serves as director of the Woods Hole Research Center and Teresa and John Heinz Professor of Environmental Policy at Harvard University.
'"/>


18-Feb-2007


Page: 1 2 3

Related biology news :

1. Journal of Nuclear Medicine releases new research faster
2. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
3. National panel led by LSU Chancellor releases report on Corps of Engineers
4. DOE JGI releases IMG 2.0 with all genomes refreshed from RefSeq
5. NSET releases document: EHS research needs for engineered nanoscale materials
6. DOE JGI sequences, releases genome of symbiotic tree fungus
7. DOE JGI releases IMG 1.5 with curated archaeal genomes
8. DOE JGI releases experimental metagenomics data management & analysis system
9. DOE JGI releases fourth version of IMG in 2005
10. Center releases new public survey on stem cells
11. DOE JGI releases latest version of IMG

Post Your Comments:
(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... YORK , June 30, 2015 To bolster ... security provider HYPR Corp. announced today the addition of two ... will serve as board advisor and David Raviv ... the team underscore HYPR Corp.,s commitment to providing the most ... Dimitri Sirota co-founded Layer 7 Technologies, a provider ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: